A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment
Some of the data from this study were presented at The European Society of Contraception in Ljubljana, Slovenia, June 28–July 1, 2000 and at the World Congress of Gynecological Endocrinology in Florence, Italy, December 8–10, 2000.
Received 8 December 2000; received in revised form 2 March 2001; accepted 2 March 2001.
☆ Supported by Wyeth-Ayerst Laboratories, St. Davids, Pennsylvania.
PII: S0015-0282(01)01938-0
© 2001 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
http://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on
SciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.